Raj Chovatiya, MD, PhD

Articles by Raj Chovatiya, MD, PhD

Novel Systemic and Topical Treatments for Plaque Psoriasis

ByRaj Chovatiya, MD, PhD,Christopher G. Bunick, MD, PhD,Jason Hawkes, MD, MS

June 19th 2023

In this episode of MEDcast, expert dermatologists discuss exciting advancements in systemic therapies such as JAK inhibitors, and the latest breakthroughs in topical treatments for plaque psoriasis.

Patient Subgroups and Educational Opportunities in Rare Dermatological Disorders

ByRaj Chovatiya, MD, PhD,Boni Elewski, MD,Carly Elston, MD,Benjamin Kaffenberger, MD

June 9th 2023

Dermatological experts discuss challenges that are associated with the use of standard and emerging treatments in special patient population.

Improving Recognition and Referral of Rare Conditions in Rare Setting

ByRaj Chovatiya, MD, PhD,Boni Elewski, MD,Benjamin Kaffenberger, MD,Carly Elston, MD

June 2nd 2023

Experts discuss how to improve recognition and referral for rare dermatologic conditions in the ER setting.

Future Treatment Outlook for Rare Dermatological Disorders

ByRaj Chovatiya, MD, PhD,Boni Elewski, MD,Benjamin Kaffenberger, MD,Carly Elston, MD

June 2nd 2023

Boni Elewski, MD, and Benjamin Kaffenberger, MD, and Carly Elston, MD, provide their clinical recommendations regarding future treatments for rare dermatological disorders.

Spesolimab for Treatment of GPP

ByRaj Chovatiya, MD, PhD,Boni Elewski, MD,Benjamin Kaffenberger, MD,Carly Elston, MD

May 26th 2023

Experts discuss spesolimab, an IL-36 inhibitor, that was recently FDA approved for treatment of GPP.

Use of Biologics in Rare Dermatologic Disorders

ByRaj Chovatiya, MD, PhD,Boni Elewski, MD,Benjamin Kaffenberger, MD,Carly Elston, MD

May 26th 2023

Experts discuss the use of biologics in the treatment of rare dermatologic disorders.

Initial Management Of Patients With Rare Dermatological Disorders

ByRaj Chovatiya, MD, PhD,Boni Elewski, MD,Benjamin Kaffenberger, MD,Carly Elston, MD

May 19th 2023

Dermatology experts review available treatment options for the treatment of rare dermatological disorders.

Challenges in Managing Rare Skin Conditions

ByRaj Chovatiya, MD, PhD,Boni Elewski, MD,Benjamin Kaffenberger, MD,Carly Elston, MD

May 19th 2023

Experts discuss challenges in managing rare dermatological disorders.

Differential Diagnosis of Rare Skin Conditions

ByRaj Chovatiya, MD, PhD,Boni Elewski, MD,Benjamin Kaffenberger, MD,Carly Elston, MD

May 12th 2023

Experts discuss what types of skin symptoms prompt patients to go to the emergency room.

Diagnosis of Rare Dermatological Disorders

ByRaj Chovatiya, MD, PhD,Boni Elewski, MD,Benjamin Kaffenberger, MD,Carly Elston, MD

May 12th 2023

Dermatology experts discuss why it is important to recognize dermatologic conditions correctly and how a misdiagnosis and delay of treatment can cause irreversible and unnecessary harm.

GPP, PPP and SJS: Typical Patient Journey

ByRaj Chovatiya, MD, PhD,Boni Elewski, MD,Benjamin Kaffenberger, MD,Carly Elston, MD

May 5th 2023

Experts discuss the typical journey of a patient with rare dermatologic conditions.

Pathophysiology of GPP, PPP, and SJS

ByRaj Chovatiya, MD, PhD,Boni Elewski, MD,Benjamin Kaffenberger, MD,Carly Elston, MD

May 5th 2023

Benjamin Kaffenberger, MD, discusses the underlying pathophysiology of GPP, PPP, and SJS.

Symptoms of Rare Dermatological Disorders

ByRaj Chovatiya, MD, PhD,Boni Elewski, MD,Benjamin Kaffenberger, MD,Carly Elston, MD

April 28th 2023

Boni Elewski, MD, and Benjamin Kaffenberger, MD, and Carly Elston, MD, reviews the symptoms that patients with generalized pustular psoriasis (GPP), palmoplantar pustulosis (PPP), acrodermatitis continua of Hallopeau, Steven-Johnson syndrome (SJS), toxic epidermal necrolysis, linear IgA bullous dermatosis (LABD), and hidradenitis suppurativa typically present with in a dermatology clinic.

Prevalence of Rare Dermatological Disorders

ByRaj Chovatiya, MD, PhD,Boni Elewski, MD,Benjamin Kaffenberger, MD,Carly Elston, MD

April 28th 2023

Experts discuss some rare dermatological disorders that critical care physicians may see in the emergency room setting or dermatologists may see in their clinics along with the prevalence of these diseases.

Recent Advances in the Treatment of Alopecia Areata

ByRaj Chovatiya, MD, PhD,George Han, MD, PhD,Brett King, MD, PhD

April 5th 2023

In this MEDcast episode, Raj Chovatiya, MD, PhD, and George Han, MD, PhD, interview Brett King, MD, PhD, to discuss the latest advances in the treatment of alopecia areata.

Management of Atopic Dermatitis in Pediatric and Adult Patients

ByRaj Chovatiya, MD, PhD,George Han, MD, PhD,Vivian Shi, MD, FAAD

April 5th 2023

In this MEDcast episode,Raj Chovatiya, MD, PhD, and George Han, MD, PhD interview Vivian Shi, MD, FAAD, to discuss the latest clinical evidence on the management of atopic dermatitis (AD) in different age groups and patient factors to consider when selecting a treatment for AD.

Physician and Patient Communication for the Management of Alopecia Areata

ByRaj Chovatiya, MD, PhD,George Han, MD, PhD,Brett King, MD, PhD

April 3rd 2023

Expert dermatologists discuss the importance of continued education for physicians treating patients with alopecia areata.

Novel Mechanisms of Action for Treatment of Alopecia Areata

ByRaj Chovatiya, MD, PhD,George Han, MD, PhD,Brett King, MD, PhD

April 3rd 2023

Dr. Brett King shares novel mechanisms of action under research for the treatment of alopecia areata in different age groups.

Analyzing Phase 3 Clinical Trial Data of Baricitinib in Alopecia Areata

ByRaj Chovatiya, MD, PhD,George Han, MD, PhD,Brett King, MD, PhD

April 3rd 2023

The expert panel discusses the secondary analysis from the phase 3 BRAVE clinical trials of baricitinib in alopecia areata.

JAK Inhibitor Baricitinib for Treatment of Alopecia Areata

ByRaj Chovatiya, MD, PhD,George Han, MD, PhD,Brett King, MD, PhD

April 3rd 2023

Drs. Raj Chovatiya, George Han, and Brett King discuss the use of baricitinib for the treatment of moderate to severe alopecia areata.

Impact of Alopecia Areata on Quality of Life, and Current Standard of Treatment

ByRaj Chovatiya, MD, PhD,George Han, MD, PhD,Brett King, MD, PhD

April 3rd 2023

The expert panel highlights the psychosocial burden of alopecia areata on patients and discusses the current treatment paradigm.

Keeping Physicians Up to Date With AD Advances

ByRaj Chovatiya, MD, PhD,Matthew Zirwas, MD,Adelaide A. Hebert, MD,Omar Noor, MD,Peter Lio, MD

March 15th 2023

Experts in dermatology share advice on helping fellow physicians stay apprised of the advances in AD and treat their patients more effectively.

Emerging Treatment Options in AD

ByRaj Chovatiya, MD, PhD,Matthew Zirwas, MD,Adelaide A. Hebert, MD,Omar Noor, MD,Peter Lio, MD

March 15th 2023

Expert dermatologists consider ongoing trials and emerging treatment options for the management of AD.

Guidance for Topical Treatment Use Based on BSA in AD

ByRaj Chovatiya, MD, PhD,Matthew Zirwas, MD,Adelaide A. Hebert, MD,Omar Noor, MD,Peter Lio, MD

March 15th 2023

Experts in dermatology share general guidance for use of topicals, switching from topical to systemic treatment, and when combination therapy is an option for patients with atopic dermatitis.

Challenges and Advantages in Use and Access to Biologics for Atopic Dermatitis

ByRaj Chovatiya, MD, PhD,George Han, MD, PhD,Vivian Shi, MD, FAAD

March 13th 2023

Drs Raj Chovatiya, George Han, and Vivian Shi review the current challenges and opportunities surrounding the utilization and availability of biologic therapies in atopic dermatitis.

Considerations for Biologic Treatments in Pediatric Patients with Atopic Dermatitis

ByRaj Chovatiya, MD, PhD,George Han, MD, PhD,Vivian Shi, MD, FAAD

March 13th 2023

Expert dermatologists highlight the burden of atopic dermatitis in young children and examine the clinical data for dupilumab, a biologic treatment for this age group.

Therapy Individualization for Atopic Dermatitis

ByRaj Chovatiya, MD, PhD,George Han, MD, PhD,Vivian Shi, MD, FAAD

March 13th 2023

The expert panel discusses the heterogeneity of atopic dermatitis manifestation and therapy decisions for individual patients.

Treatment Landscape in Atopic Dermatitis for Different Age Groups

ByRaj Chovatiya, MD, PhD,George Han, MD, PhD,Vivian Shi, MD, FAAD

March 13th 2023

Dr Vivian Shi provides an overview of treatment options for atopic dermatitis patients in different age groups.

Monitoring AD Treatments in Various Age Groups

ByRaj Chovatiya, MD, PhD,Matthew Zirwas, MD,Adelaide A. Hebert, MD,Omar Noor, MD,Peter Lio, MD

March 8th 2023

Omar Noor, MD, and Adelaide A. Hebert, MD, discuss monitoring requirements for various classes of treatments in atopic dermatitis, including topical vs systemic.